Mouse models expressing human carcinoembryonic antigen (CEA) as a transgene: Evaluation of CEA-based cancer vaccines
- 25 August 2005
- journal article
- review article
- Published by Elsevier in Mutation Research
- Vol. 576 (1-2), 132-154
- https://doi.org/10.1016/j.mrfmmm.2004.10.014
Abstract
No abstract availableKeywords
This publication has 123 references indexed in Scilit:
- Novel mouse model for carcinoembryonic antigen-based therapyMolecular Therapy, 2004
- A Randomized Trial of Aspirin to Prevent Colorectal AdenomasNew England Journal of Medicine, 2003
- A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal CancerNew England Journal of Medicine, 2003
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Intestinal polyposis in mice with a dominant stable mutation of the beta -catenin geneThe EMBO Journal, 1999
- The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissuesSeminars in Cancer Biology, 1999
- Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory diseaseNature, 1992
- Cell adhesion activity of non-specific cross-reacting antigen (NCA) and carcinoembryonic antigen (CEA) expressed on CHO cell surface: Homophilic and heterophilic adhesionBiochemical and Biophysical Research Communications, 1989
- Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion moleculeCell, 1989
- Primary structure of human carcinoembryonic antigen (CEA) deduced from cDNA sequenceBiochemical and Biophysical Research Communications, 1986